InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related services in the United States and Canada. The company supplies electronic ambulatory infusion pumps and associated disposable kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer. It also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps to oncology practices; and provides biomedical certification, maintenance, and repair services for oncology practices, as well as to other alternate site settings, including home care and home infusion providers, skilled nursing facili...
31700 Research Park Drive
Madison Heights, MI 48071-4627
Founded in 2005
InfuSystem Holdings, Inc. Presents at Sidoti & Company Emerging Growth Institutional Investor Forum, Jan-12-2015 11:20 AM
Jan 6 15
InfuSystem Holdings, Inc. Presents at Sidoti & Company Emerging Growth Institutional Investor Forum, Jan-12-2015 11:20 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Eric K. Steen, Chief Executive Officer, President and Director.
InfuSystem Holdings, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Maintains Earnings Guidance for the Year 2014
Nov 10 14
InfuSystem Holdings, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the third quarter, the company reported net revenues of $16,613,000 against $15,740,000 a year ago. Operating income was $2,443,000 against $1,923,000 a year ago. Income before income taxes was $1,694,000 against $1,078,000 a year ago. Net income was $852,000 or $0.04 per basic and diluted share against $649,000 or $0.03 per basic and diluted share a year ago. EBITDA was $4,006,000 against $3,929,000 a year ago. EBITDA-adjusted was $4,151,000 against $4,255,000 a year ago.
For the nine months, the company reported net revenues of $50,227,000 against $45,103,000 a year ago. Operating income was $6,557,000 against $3,436,000 a year ago. Income before income taxes was $4,228,000 against $1,129,000 a year ago. Net income was $2,321,000 or $0.10 per basic and diluted share against $805,000 or $0.04 per basic and diluted share a year ago. Net cash provided by operating activities was $4,204,000 against $4,765,000 a year ago. The decrease in cash provided is primarily due to changes in accounts payable and other accruals. Purchase of medical equipment and property was $7,168,000 against $3,396,000 a year ago. EBITDA was $11,054,000 against $9,747,000 a year ago. EBITDA-adjusted was $11,471,000 against $11,271,000 a year ago. The increase in Revenue was primarily related to net additional rental and sales customers and increased penetration into existing rental and sales customer accounts, offset by a higher mix of Medicaid and patient payors in the company's rental business. These generally have lower net revenue rates than commercial payors. Such shifts have come, the Company believes, due to the Affordable Care Act. Total debt less cash on hand (‘net debt’) as of September 30, 2014 was $26,000,000 compared to last fiscal year of $25,600,000 as of September 30, 2013.
The company maintained 2014 guidance of high single digit revenue growth and announced that it expects this rate to continue through 2015.
InfuSystem Holdings, Inc. Presents at LD Micro Conference, Dec-02-2014 04:30 PM
Nov 8 14
InfuSystem Holdings, Inc. Presents at LD Micro Conference, Dec-02-2014 04:30 PM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard, Los Angeles, California, United States. Speakers: Eric K. Steen, Chief Executive Officer, President and Director.